These trials, including the PIONEER (Peptide Innovation for Early Diabetes Treatment) 2 trial, used oral semaglutide rather than injectable semaglutide and found that standard doses of up to 14 milligrams (mg) of oral semaglutide were safe and effective when combined with daily metformin doses of at least 1,500 mg
I have more energy than ever and have lost weight immediately weeks after starting
Hypoglycemia Risk: Concomitant use with oral insulin secretagogues (e.g., sulfonylureas) or exogenous insulin increases the risk of hypoglycemia, requiring a defensive reduction of those co-prescribed agents
Patient Variability and Considerations Each patient reacts differently to these medications
This suggests a potential role for phentermine as a maintenance or bridge therapy after GLP-1 discontinuation, though the evidence remains preliminary
We proudly serve patients across North Texas, including Fort Worth, Denton, Frisco, Plano, Denison, Dallas, Tom Bean, and the surrounding communities